Compremium

Compremium is a private, commercial-stage medtech company addressing a critical blind spot in orthopaedic trauma: the objective assessment of dynamic soft tissue conditions. The company's proprietary technology platform quantifies tissue 'compressibility,' a metric that correlates with intra-compartmental pressure, offering a standardized alternative to subjective palpation. With regulatory approvals in key markets and a growing body of clinical evidence, Compremium is positioned to improve patient monitoring and surgical timing decisions from triage to discharge. Its technology also shows promise in adjacent applications like non-invasive venous pressure measurement.

Proprietary sensor-based platform that quantifies soft tissue 'compressibility' (response to defined pressure) and 'occlusion pressure' for venous pressure estimation. The platform uses defined protocols to provide objective, non-invasive measurements correlated with invasive clinical standards like intra-compartmental and central venous pressure.

In ortho trauma, Compremium's direct competitors are other non-invasive compartment pressure monitors (e.g., using near-infrared spectroscopy) and the entrenched standard of invasive needle manometry. In venous pressure monitoring, it faces competition from large, established vital sign monitoring companies and invasive CVP measurement. Its competitive edge is strong clinical validation, regulatory clearance, and a unique focus on tissue compressibility as a metric.